Commit To Buy Krystal Biotech At $140, Earn 12.5% Using Options

Investors considering a purchase of Krystal Biotech Inc (KRYS) stock, but cautious about paying the going market price of $185.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December 2025 put at the $140 strike, which has a bid at the time of this writing of $17.50..